原发性卵巢功能不全基因组拷贝数变异的系统映射与计算机再评估
该研究遵循PRISMA指南系统综述25项研究,汇总382个拷贝数变异(CNV),标准化基因组坐标并过滤人群数据库。按ACMG/ClinGen指南再评估得到42个致病/可能致病变异和25个大于3.5 Mb的大CNV,X染色体CNV负荷最高。在断裂位点内识别出ATF3、GAS5、PPP4R1和PRKAA1等高卵巢表达候选基因,建议扩展临床检测面板。
要点
- X染色体CNV负荷最高,在POI结构基因组不稳定中居核心地位。
- 再评估得42个致病/可能致病变异和25个大于3.5 Mb的大CNV。
- ATF3、GAS5、PPP4R1、PRKAA1等高卵巢表达基因未纳入多数商业POI诊断面板。
核心结论
- POI结构基因组景观复杂,扩展临床检测面板纳入被低估基因可能提高遗传未解释病例的诊断率。
研究设计与样本
- 系统综述与计算机基因组再分析,遵循PRISMA指南,汇总25项研究的382个CNV,标准化坐标并过滤人群数据库。
主要发现
- X染色体CNV负荷最高。
- 再评估得42个致病/可能致病变异和25个大于3.5 Mb的大CNV。
- 在断裂位点内识别出ATF3、GAS5、PPP4R1和PRKAA1等高卵巢表达候选基因。
关键数值与推荐
- 按ACMG/ClinGen指南再评估致病性,得到42个致病/可能致病变异和25个大于3.5 Mb的大CNV。
临床怎么用
- 对遗传未解释的POI病例,可考虑检测面板扩展纳入ATF3、GAS5、PPP4R1和PRKAA1等候选基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary ovarian insufficiency (POI) is a highly heterogeneous condition characterized by the cessation of ovarian function before age 40. While genetic factors play a substantial role, the contribution of structural variants remains incompletely mapped. We conducted a systematic review and in silico genomic re-analysis of published copy number variations (CNVs) in individuals with POI. Following PRISMA guidelines, we aggregated 382 CNVs from 25 studies, standardized genomic coordinates, and filtered variants against population databases. Pathogenicity was reevaluated using ACMG/ClinGen guidelines, yielding 42 pathogenic/likely pathogenic variants and 25 large CNVs (>3.5 Mb). Consistent with previous findings, the X chromosome exhibited the highest CNV burden, emphasizing its central role in structural genomic instability and POI pathogenesis. Beyond canonical POI-associated genes, gene ontology and GTEx expression profiling identified several biologically plausible, highly ovary-expressed candidate genes within disrupted loci-notably ATF3, GAS5, PPP4R1, and PRKAA1. Despite their established roles in cellular stress responses, DNA repair, and meiotic progression, these genes remain absent from most commercial POI diagnostic panels. This comprehensive re-analysis highlights the complex structural genomic landscape of POI and suggests that expanding current clinical testing panels to include these under-recognized genes could improve diagnostic yields for genetically unexplained cases.
引用
- Hossein Garakani M, Kakavand K, Hajiesmaeili Y, et al. Systematic mapping and in silico reevaluation of genomic copy number variations in primary ovarian insufficiency. J Clin Endocrinol Metab. 2026. PMID: 42126082. doi:10.1210/clinem/dgag202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。